Granahan Investment Management - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,895,605
-72.1%
76,120
-33.1%
0.10%
-67.7%
Q2 2023$10,364,903
-3.9%
113,775
-30.4%
0.32%
-2.7%
Q1 2023$10,781,228
+14.2%
163,451
-10.4%
0.33%
+13.5%
Q4 2022$9,437,489
+1.1%
182,508
+33.5%
0.29%
-5.2%
Q3 2022$9,339,000
+45.9%
136,735
-3.4%
0.30%
+39.3%
Q2 2022$6,403,000
-18.1%
141,592
-8.0%
0.22%
+12.9%
Q1 2022$7,821,000
+97.8%
153,923
+84.1%
0.19%
+139.5%
Q4 2021$3,953,00083,6010.08%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders